JOHN YATES, M.D., is president of Takeda Global Research and Development Center Inc. Previously, he served as vice president, Medical and Scientific Affairs (MEDSA) of Merck & Co. Prior to joining MEDSA, Dr.Yates was vice president of clinical development in the U.S. Human Health Division of Merck. He also worked with the then-nascent osteoporosis clinical research team at Merck and subsequently led that team in the development of bisphosphonate alendronate (Fosamax) for treatment and prevention of postmenopausal osteoporosis.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement